Real-world survival outcomes with first-line chemoimmunotherapy and biomarker analysis in extensive-stage small-cell lung cancer
Clinical and Translational Oncology · 31.10.2025 · 28 (4) · 1267-1276
DOI: 10.1007/s12094-025-04097-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Translational Oncology, erschienen am 31.10.2025. Verfasst von Emmanouil Panagiotou und 12 weiteren Autor:innen. Beteiligte Einrichtung: Third Department of Internal Medicine, Sotiria Thoracic Diseases Hospital of Athens, National and Kapodistrian University of Athens, 152, Mesogion Av…. Hauptthemen laut MEDLINE: Small Cell Lung Carcinoma, Lung Neoplasms, Biomarkers, Tumor, Immunotherapy. Die Arbeit nennt 41 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Third Department of Internal Medicine, Sotiria Thoracic Diseases Hospital of Athens, National and Kapodistrian University of Athens, 152, Mesogion Ave., 11527, Athens, Greece.
- Third Department of Internal Medicine, Sotiria Thoracic Diseases Hospital of Athens, National and Kapodistrian University of Athens, 152, Mesogion Ave., 11527, Athens, Greece. johnvathiotis1@gmail.com.
- Institute for Personalized Medicine, Department of Biochemistry and Molecular Biology, The Pennsylvania State University College of Medicine, Hershey, PA, USA.
- Huck Institutes of the Life Sciences, Pennsylvania State University, University Park, PA, USA.
Zitieren
APA
Panagiotou, E., Vathiotis, I. A., Montgomery, A., Moeckel, C., Livanou, M., Mastrogeorgiou, M., Trimis, A., Trontzas, I., Syrigos, N. K., Mouratidis, I., Evangelou, G., Georgakopoulos-Soares, I., & Syrigos, K. N. (2025). Real-world survival outcomes with first-line chemoimmunotherapy and biomarker analysis in extensive-stage small-cell lung cancer. Clinical and Translational Oncology. https://doi.org/10.1007/s12094-025-04097-4
Vancouver
Panagiotou E, Vathiotis IA, Montgomery A, Moeckel C, Livanou M, Mastrogeorgiou M, et al. Real-world survival outcomes with first-line chemoimmunotherapy and biomarker analysis in extensive-stage small-cell lung cancer. Clinical and Translational Oncology. 2025. doi:10.1007/s12094-025-04097-4
BibTeX
@article{Panagiotou2025,
author = {Panagiotou, Emmanouil and Vathiotis, Ioannis Athanasios and Montgomery, Austin and Moeckel, Camille and Livanou, Mirsini and Mastrogeorgiou, Michail and Trimis, Athanasios and Trontzas, Ioannis and Syrigos, Nikolaos Konstantinos and Mouratidis, Ioannis and Evangelou, Georgios and Georgakopoulos-Soares, Ilias and Syrigos, Konstantinos Nikolaos},
title = {Real-world survival outcomes with first-line chemoimmunotherapy and biomarker analysis in extensive-stage small-cell lung cancer},
journal = {Clinical and Translational Oncology},
year = {2025},
doi = {10.1007/s12094-025-04097-4}
}
EUVIMED